51
|
Vidhya D, Ramalingam S, Periandy S, Aarthi R. Crystal property and spectroscopic investigation on electro-optic and physico-chemical properties of NLO crystal; 3-(3,4-Dihydroxyphenyl)-L-Alanine. Heliyon 2019; 5:e03055. [PMID: 32083203 PMCID: PMC7019075 DOI: 10.1016/j.heliyon.2019.e03055] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2019] [Revised: 11/06/2019] [Accepted: 12/11/2019] [Indexed: 11/22/2022] Open
Abstract
In this attempt, in order to obtain high-quality NLO crystal, organic compound; 3-(3,4-Dihydroxyphenyl)-L-Alanine crystal was fabricated. The organic-composite crystal was characterized by crystallographic and spectroscopic tools. The NLO supported parameters like crystal lattice (orthorhombic) and space group (P212121) examined and validated by XRD examination. The SHG test was carried out and SHG efficiency was calculated that1.29 and 1.35 times greater than solid KDP crystal. The laser damage threshold energy density was determined to be 14.51 GW/cm2. By the application of mulliken charge assignment, multiple dielectric cavities were found in crystal material which is able to process the high degree of birefringence gradient. The oscillating chemical potential movement was observed by examining chemical shift, among the core carbons of hexagonal ring and bridge carbons of chain. The chemical softness insists the binding viability of further ligand groups. The π and δ-conjugated interactive complex orbitals recognized on molecular site and participation in optical active mechanism was identified. UV-Visible transmission characteristics of crystal were studied and UV-Visible absorption on degenerate energy states was noted and its band gap energy was estimated. The CT complex of the present case was acknowledged to be COOH group and it causing crystal properties of current organic composite. The hyperactive polarizability was determined as 1775.05 × 10-33 esu and it was found to be five times greater than thiourea. The depletion energy between highly electrophilic zones and protonic zones was estimated to be ±5.241 e 2 causing permanent dielectric characteristics for the title organic composite. The non-superposable on the molecular mirror image was displayed and thereby optical ability was validated.
Collapse
Affiliation(s)
- D. Vidhya
- Department of Physics, A.V.C. College, Mayiladuthurai, Tamilnadu, India
| | - S. Ramalingam
- Department of Physics, A.V.C. College, Mayiladuthurai, Tamilnadu, India
| | | | - R. Aarthi
- Department of Physics, ST. Theresa's College of Arts and Science, Tharangambadi, Tamilnadu, India
| |
Collapse
|
52
|
Smeltzer M, Wynes M, Lantuejoul S, Soo R, Dalurzo L, Felip E, Hollenbeck G, Howell K, Kerr K, Kim E, Mathias C, Postmus P, Powell C, Ramalingam S, Richeimer K, Taylor M, Tsuboi M, Varella-Garcia M, Wistuba I, Wood K, Scagliotti G, Hirsch F. OA01.09 Comparing Regional Results from the IASLC Global Survey on Molecular Testing in Lung Cancer. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.09.023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
53
|
Hemachandran K, Anbusrinivasan P, Ramalingam S, Aarthi R, Nithya C. Structural activity analysis, spectroscopic investigation, biological and chemical properties interpretation on Beta Carboline using quantum computational methods. Heliyon 2019; 5:e02788. [PMID: 31844720 PMCID: PMC6895699 DOI: 10.1016/j.heliyon.2019.e02788] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2019] [Revised: 09/07/2019] [Accepted: 11/01/2019] [Indexed: 12/31/2022] Open
Abstract
In this methodological work, the structural activity analysis have been carried out on β-Carboline to study the anti cancer activity and the way of improving the biological activity. The molecular spectroscopic tools were used to evaluate all the experimental data like spectral results and data were validated by the computational, HyperChem and Osiris tools. The structural, biological and physico-chemical related analyses have been performed to interpret the properties. The GPCR ligand calculated to be 0.11 for generating pharmacokinetic process, Specified drug information for the compound, was congregated from all types of structural activity which was drawn by spectral and HyperChem data. The σ and π interaction band gap (6.18 eV) ensured the drug consistency. The Mulliken charge process distribution was mapped, the charge orientation assignment was checked; the acquired negative charge potential consignment for the cause of antibiotic impact was verified. The molecular orbital interaction study was carried out to identify the origination of degeneracy of interaction causing drug mechanism. Using NMR spectral pattern, the chemical reaction path was recognized and the nodal region dislocation was distinguished on chemical shift. The Electronegativity (χ) and Electrophilicity charge transfer found to be 3.83 and 0.215, confirmed charge complex transfer for activating drug process in the compound. The molecular nonbonding section was thoroughly observed in order to find the occupancy energy, was the key process to initiate drug activity. The bathochromic electronic shift was observed and the existence of CT complex was discussed. The hindering of toxicity was inspected on inevitable chirality of the compound by specifying VCD spectrum.
Collapse
Affiliation(s)
- K. Hemachandran
- Department of Chemistry, A.V.C. College, Mayiladuthurai, Tamilnadu, India
| | - P. Anbusrinivasan
- Department of Chemistry, A.V.C. College, Mayiladuthurai, Tamilnadu, India
| | - S. Ramalingam
- Department of Physics, A.V.C. College, Mayiladuthurai, Tamilnadu, India
| | - R. Aarthi
- Department of Physics, ST. Theresas College of Arts and Science, Tharangambadi, Tamilnadu, India
| | - C.K. Nithya
- Department of Physics, ST. Theresas College of Arts and Science, Tharangambadi, Tamilnadu, India
| |
Collapse
|
54
|
Nageswari G, George G, Ramalingam S, Govindarajan M. Molecular analyses using FT-IR, FT-Raman and UV spectral investigation; quantum chemical calculations of dimethyl phthalate. J Mol Struct 2019. [DOI: 10.1016/j.molstruc.2019.05.098] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
55
|
Garcia M, Smeltzer M, Wynes M, Lantuejoul S, Soo R, Dalurzo L, Felip E, Howell K, Kerr K, Kim E, Mathias C, Postmus P, Powell C, Ramalingam S, Richeimer K, Taylor M, Tsuboi M, Wistuba I, Wood K, Scagliotti G, Hirsch F. O.04 Results from the IASLC Global Survey on Molecular Testing in Lung Cancer. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.09.091] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
56
|
Reungwetwattana T, Gray J, Markovets A, Nogami N, Lee J, Cho B, Chewaskulyong B, Majem M, Peled N, Vishwanathan K, Todd A, Rukazenkov Y, Johnson M, Barrett C, Chmielecki J, Hartmaier R, Ramalingam S. Longitudinal circulating tumour DNA (ctDNA) monitoring for early detection of disease progression and resistance in advanced NSCLC in FLAURA. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz446.016] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
57
|
Obeng R, Behera M, Owonikoko T, Pillai R, Ahmed R, Ramalingam S, Sica G. P1.15 The Presence of Secondary Follicles in Early Stage Lung Adenocarcinoma Reflects Disease Burden. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.09.072] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
58
|
Ramalingam S, Lopez J, Mau-Sorensen M, Thistlethwaite F, Piha-Paul S, Gadgeel S, Drew Y, Jänne P, Mansfield A, Chen G, Forssmann U, Johannsdottir H, Pencheva N, Ervin-Haynes A, Vergote I. OA02.05 First-In-Human Phase 1/2 Trial of Anti-AXL Antibody–Drug Conjugate (ADC) Enapotamab Vedotin (EnaV) in Advanced NSCLC. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.414] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
59
|
Ramalingam S, Dinan M, Crawford J. OA11.03 Survival Disparities Between Academic and Community Centers in Advanced Lung Cancer in the US: Can We Bridge the Gap? J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.467] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
60
|
Rashdan S, Dahlberg S, Gerber D, Sandler A, Schiller J, Johnson D, Ramalingam S. OA07.05 High-Grade Chemotherapy-Induced Peripheral Neuropathy (CIPN): An Analysis of ECOG-ACRIN Lung Cancer Clinical Trials. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.444] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
61
|
Bazhenova L, Redman M, Gettinger S, Hirsch F, Mack P, Schwartz L, Gandara D, Bradley J, Stinchcombe T, Leighl N, Ramalingam S, Tavernier S, Minichiello K, Kelly K, Papadimitrakopoulou V, Herbst R. OA04.01 A Phase III Randomized Study of Nivolumab/Ipilimumab vs Nivolumab for Previously Treated Stage IV Squamous Cell Lung Cancer. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.423] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
62
|
Aarthi R, Ramalingam S, Periandy S. Pharmaceutical property interpretation and biological property study on Ethionamide using quantum spectroscopic and computational tools. Journal of Taibah University for Science 2019. [DOI: 10.1080/16583655.2019.1661133] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Affiliation(s)
- R. Aarthi
- Department of Physics, A.V.C. College, Mayiladuthurai, India
- Department of Physics, ST. Theresas college of Arts and Science, Thrangambadi, India
| | - S. Ramalingam
- Department of Physics, A.V.C. College, Mayiladuthurai, India
| | - S. Periandy
- Department of Physics, Kanchi Mamunivar centre for PG studies, Puducherry, India
| |
Collapse
|
63
|
Escott C, Madden N, Schreibmann E, Tian S, Cassidy R, Sutter A, Whitaker D, Switchenko J, Pfister N, Xu K, Force S, Ramalingam S, Curran W, Higgins K, Patel P. Radiomic Analysis of Radiation Induced Fibrosis Following Stereotactic Body Radiation Therapy. Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.1327] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
64
|
Mollan SP, Davis B, Silver NC, Shaw S, Malucci C, Wakerley BR, Krishnan A, Chavda SV, Ramalingam S, Edwards J, Hemmings K, Williamson M, Burdon MA, Hassan-Smith G, Digre K, Liu GT, Jensen RH, Sinclair AJ. TM3-1 Idiopathic intracranial hypertension: consensus guidelines on investigation and management. J Neurol Psychiatry 2019. [DOI: 10.1136/jnnp-2019-abn.47] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
ObjectivesThe aim was to capture interdisciplinary expertise from a large group of clinicians, reflecting practice from across the UK and further, to inform subsequent development of a national consensus guidance for optimal management of Idiopathic Intracranial Hypertension.DesignConsensus guideline critically reviewed by the Association of British Neurologists, British Association for the Study of Headache, the Society of British Neurological Surgeons and the Royal College of Ophthalmologists.SubjectsAn initial UK survey of attitudes and practice in IIH was sent to a wide group of physicians and surgeons.MethodsBetween September 2015 and October 2017 a specialist interest group including neurology, neurosurgery, neuro-radiology, ophthalmology, nursing, primary care doctors, and patient representatives met. A comprehensive systematic literature review was performed to assemble the foundations of the statements.ResultsOver twenty questions were constructed: One based on the diagnostic principles for optimal investigation of papilloedema and twenty-one for the management of IIH. 3 main principles were identified:to treat the underlying disease;to protect the vision andto minimise the headache morbidity.Statements presented provide insight to uncertainties in IIH where research opportunities exist.ConclusionsIn collaboration with many different specialists, professions and patient representatives we have developed guidance statements for the investigation and management of adult IIH.
Collapse
|
65
|
Peters S, Dafni U, Boyer M, De Ruysscher D, Faivre-Finn C, Felip E, Garrido P, Girard N, Guckenberger M, Haanen J, Le Pechoux C, Mornex F, Ozsahin M, Paz-Ares L, Planchard D, Raben D, Ramalingam S, Reck M, Smit E, Stahel R, Stenzinger A, Swanton C, Vallone S, Garassino MC. Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP). Ann Oncol 2019; 30:161-165. [PMID: 30624547 DOI: 10.1093/annonc/mdy553] [Citation(s) in RCA: 50] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/08/2023] Open
Affiliation(s)
- S Peters
- Oncology Department, Lausanne University and CHUV, Lausanne, Switzerland.
| | - U Dafni
- Laboratory of Biostatistics, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece
| | - M Boyer
- Chris O'Brien Lifehouse, Camperdown, Australia
| | - D De Ruysscher
- GROW School for Oncology and Developmental Biology, Maastricht University Medical Center+, Department of Radiation Oncology (Maastro Clinic), Maastricht, The Netherlands
| | - C Faivre-Finn
- Department of Clinical Oncology, The Christie NHS Foundation Trust & University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
| | - E Felip
- Oncology Department, Vall d'Hebron University, Vall d'Hebron Institute of Oncology, Barcelona, Spain
| | - P Garrido
- Medical Oncology Department, Ramón y Cajal University Hospital, Madrid, Spain
| | - N Girard
- Thorax Institute, Institute Curie, Paris, France
| | - M Guckenberger
- Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland
| | - J Haanen
- Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands
| | - C Le Pechoux
- Department of Radiation Oncology, Gustave Roussy, Villejuif, France
| | - F Mornex
- Université Claude Bernard Lyon1, and Hospices Civils de Lyon, Lyon, France
| | - M Ozsahin
- Department of Radiation Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
| | - L Paz-Ares
- Department of Medical Oncology, Hospital Universitario 12 de Octubre, CNIO & Universidad Complutense, Madrid, Spain
| | - D Planchard
- Department of Medical Oncology, Thoracic Group, Gustave Roussy, Villejuif, France
| | - D Raben
- Marsico Family Endowed Chair of Head and Neck Cancer Research, University of Colorado Cancer Center, Aurora, USA
| | - S Ramalingam
- Department of Hematology and Medical Oncology, Emory University School of Medicine and Winship Cancer Institute, Atlanta, USA
| | - M Reck
- LungenClinic, Airway Research Center North (ARCN), German Center for Lung Research, Grosshansdorf, Germany
| | - E Smit
- Egbert Smit, Department Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands
| | - R Stahel
- Chair Comprehensive Cancer Center Zürich, Universitätspital Zurich, Zurich, Switzerland
| | - A Stenzinger
- Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany
| | - C Swanton
- Cancer Evolution and Genome Stability Laboratory, The Francis Crick Institute and UCL Cancer Institute, UK
| | - S Vallone
- Lung Cancer Europe (LuCE), Bern, Switzerland
| | - M C Garassino
- Thoracic Oncology, Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
| |
Collapse
|
66
|
Hemachandran K, Anbusrinivasan P, Ramalingam S, Manoharan C, Aarthi R. Biological and structural properties’ interpretation on antitumour drug 3-(2-aminoethyl) indole (tryptamine) using molecular spectroscopy and computational tools. Journal of Taibah University for Science 2018. [DOI: 10.1080/16583655.2018.1559008] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Affiliation(s)
- K. Hemachandran
- Department of Chemistry, A.V.C. College, Mayiladuthurai, India
| | | | - S. Ramalingam
- Department of Physics, A.V.C. College, Mayiladuthurai, India
| | - C. Manoharan
- Department of Physics, Annamalai University, Chidambaram, India
| | - R. Aarthi
- Department of Physics, A.V.C. College, Mayiladuthurai, India
| |
Collapse
|
67
|
Saba N, Force S, Staley C, Fernandez F, Willingham F, Pickens A, Cardona K, Chen Z, Goff L, Cardin D, Lambright E, Nesbitt J, Higgins K, Harvey R, Owonikoko T, Ramalingam S, Shin D, Beitler J, El-rayes B, Salaria S, El-Rifai W, Landry J, Chakravarthy A. Pilot Study of Potential Activation of c-MYC by Aurora Kinase A in Everolimus-Resistant Localized Esophageal Cancer Treated with XELOX followed by Carboplatin/Radiation. Int J Radiat Oncol Biol Phys 2018. [DOI: 10.1016/j.ijrobp.2018.07.510] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
68
|
Press R, Buchwald Z, Steuer C, Pillai R, Owonikoko T, Ramalingam S, Curran W, Higgins K. Report of Neurotoxicity after Concurrent Whole Brain Radiation Therapy and Checkpoint Blockade Immunotherapy for Patients with Brain Metastases. Int J Radiat Oncol Biol Phys 2018. [DOI: 10.1016/j.ijrobp.2018.07.1038] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
69
|
Ramalingam S. PC07.01 Debate 1: Chemotherapy Will Become a Thing of the past in the Management of Advanced NSCLC - For. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.112] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
70
|
Hellmann M, Jänne P, Opyrchal M, Hafez N, Raez L, Gabrilovich D, Wang F, Ordentlich P, Brouwer S, Sankoh S, Schmidt E, Meyers M, Ramalingam S. OA05.01 Efficacy/Safety of Entinostat (ENT) and Pembrolizumab (PEMBRO) in NSCLC Patients Previously Treated with Anti-PD-(L)1 Therapy. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.257] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
71
|
Brown H, Vansteenkiste J, Nakagawa K, Cobo Dols M, John T, Barker C, Kohlmann A, Todd A, Saggese M, Chmielecki J, Markovets A, Ramalingam S. MA15.03 PD-L1 Expression in Untreated EGFRm Advanced NSCLC and Response to Osimertinib and SoC EGFR-TKIs in the FLAURA Trial. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.441] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
72
|
Owonikoko T, Dahlberg S, Sica G, Poirier J, Byers L, Rudin C, Wistuba I, Ramalingam S. P3.12-06 SLFN11 Expression and Efficacy of PARP Inhibitor Therapy in Extensive Stage Small Cell Lung Cancer: ECOG-ACRIN 2511 Study. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.1829] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
73
|
Patel J, Lee J, Wagner H, Carbone D, Shanker A, Horn L, Johnson M, Gerber D, Liu J, Das M, Ali Al-Nsour M, Dakhil C, Ramalingam S, Schiller J. MA05.01 E6508: Phase II Study of Immunotherapy with Tecemotide and Bevacizumab after Chemoradiation in Unresectable Stage III NS-NSCLC. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.349] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
74
|
Oxnard G, Mandrekar S, Hillman S, Tan A, Govindan R, Wigle D, Malik S, Watt C, Gerber D, Chaft J, Dahlberg S, Kelly K, Faggen M, Stella P, Tazi K, Gandara D, Ramalingam S, Stinchcombe T. P1.16-47 Adjuvant Targeted Therapy Following Standard Adjuvant Therapy for Resected NSCLC: An Initial Report from ALCHEMIST (Alliance A151216). J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.1016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
75
|
Nageswari G, George G, Ramalingam S, Govindarajan M. Electronic and vibrational spectroscopic (FT-IR and FT-Raman) investigation using ab initio (HF) and DFT (B3LYP and B3PW91) and HOMO/LUMO/MEP analysis on the structure of l -serine methyl ester hydrogen chloride. J Mol Struct 2018. [DOI: 10.1016/j.molstruc.2018.04.014] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
76
|
Iyappan G, Shanmugaraj B, Inchakalody V, Ma JC, Ramalingam S. Potential of plant biologics to tackle the epidemic like situations - case studies involving viral and bacterial candidates. Int J Infect Dis 2018. [DOI: 10.1016/j.ijid.2018.04.4236] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
|
77
|
Schild S, Fan W, Stinchcombe T, Vokes E, Ramalingam S, Bradley J, Kelly K, Pang H, Wang X. OC-0492: A pooled analysis of radiotherapy dose & targeting strategies for stage 3 non-small cell lung cancer. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)30802-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
78
|
Aarthi R, Ramalingam S, Periandy S, Senthil Kannan K. Molecular structure-associated pharmacodynamic investigation on benzoyl peroxide using spectroscopic and quantum computational tools. Journal of Taibah University for Science 2018. [DOI: 10.1080/16583655.2018.1451116] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Affiliation(s)
- R. Aarthi
- Department of Physics, A.V.C. College, Mayiladuthurai, India
| | - S. Ramalingam
- Department of Physics, A.V.C. College, Mayiladuthurai, India
| | - S. Periandy
- Department of Physics, Kanchi Mamunivar Centre for PG Studies, Puducherry, India
| | - K. Senthil Kannan
- Department of Physics, Dean R & D, EGS Pillay Arts and Science College, Nagapattinam, India
| |
Collapse
|
79
|
Ramalingam S, Manzoor Ali M, George G, Manthiri AA, Periandy S. Vibrational investigation on pharmaceutical activity of m-xylene-4-sulphonic acid by quantum computational and experimental support. Journal of Taibah University for Science 2018. [DOI: 10.1080/16583655.2018.1451115] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Affiliation(s)
- S. Ramalingam
- Department of Physics, A.V.C. College, Mayiladuthurai, India
| | | | - Gene George
- Department of Physics, T.B.M.L. College, Porayar, India
| | - A. Abbas Manthiri
- Department of Physics, Jamal Mohamed College, Tiruchirappalli, India
| | - S. Periandy
- Department of Physics, Kanchi Mamunivar Centre for PG Studies, Puducherry, India
| |
Collapse
|
80
|
Gray J, Okamoto I, Sriuranpong V, Vansteenkiste J, Imamura F, Lee J, Pang Y, Cobo M, Kasahara K, Hodge R, Lentrichia B, Dearden S, Ramalingam S. OA 05.02 Osimertinib vs SoC EGFR-TKI as First-Line Treatment in Patients with EGFRm Advanced NSCLC (FLAURA): Plasma ctDNA Analysis. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.348] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
81
|
Kris M, Aisner D, Sholl L, Berry L, Rossi M, Chen H, Fujimoto J, Moreira A, Ramalingam S, Villaruz L, Otterson G, Haura E, Politi K, Glisson B, Cetnar J, Garon E, Schiller J, Waqar S, Sequist L, Brahmer J, Shyr Y, Kugler K, Wistuba I, Johnson B, Minna J, Bunn P, Kwiatkowski D. P3.03-007 LCMC2: Expanded Profiling of Lung Adenocarcinomas Identifies ROS1 and RET Rearrangements and TP53 Mutations as a Negative Prognostic Factor. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.1633] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
82
|
Pillai R, Ramalingam S, Paz-Ares L, Thayu M, Watson P, Reck M. P3.04-008 A Phase 1b/2 Study of Atezolizumab With or Without Daratumumab in Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC). J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.1666] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
83
|
Piotrowska Z, Nagy R, Fairclough S, Lanman R, Marcoux N, Gettinger S, Owonikoko T, Ramalingam S, Sequist L. OA 09.01 Characterizing the Genomic Landscape of EGFR C797S in Lung Cancer Using ctDNA Next-Generation Sequencing. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.375] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
84
|
Owonikoko T, Dahlberg S, Poirier J, Sica G, Rudin C, Ramalingam S. OA 08.06 Exploratory Analysis for Predictors of Benefit of PARP Inhibitor Therapy in Extensive Stage Small Cell Lung Cancer: ECOG-ACRIN 2511 Study. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.373] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
85
|
Ramalingam S, Dinan M, Crawford J. 4B.02 Increasing Survival in Stage IV NSCLC in Academic versus Community Based Centers in the National Cancer Database. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.029] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
86
|
Higgins K, Pillai R, Chen Z, Zhang C, Patel P, Pakkala S, Shelton J, Force S, Fernandez F, Steuer C, Owonikoko T, Ramalingam S, Bradley J, Curran W. P1.08-003 Concomitant Chemotherapy and Radiotherapy with SBRT Boost for Unresectable, Stage III Non-Small Cell Lung Cancer: A Phase I Study. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.966] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
87
|
Behera M, Jiang R, Higgins K, Pillai R, Owonikoko T, Belani C, Khuri F, Ward K, Curran W, Ramalingam S. P3.13-027 Utilization of PET Scan in Advanced Stage Non-Small Cell Lung Cancer in the United States. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.1762] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
88
|
Gandara D, Herbst R, Mok T, Ramalingam S, Obholz K, Quill T, Chow H, Scagliotti G. MA 07.14 Change in Practice Patterns from an Online NSCLC Treatment Decision Support Tool. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.514] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
89
|
Vansteenkiste J, Reungwetwattana T, Nakagawa K, Cho B, Dols M, Cho E, Bertolini A, Bohnet S, Zhou C, Lee K, Nogami N, Okamoto I, Leighl N, Hodge R, McKeown A, Brown A, Rukazenkov Y, Ramalingam S. CNS response to osimertinib vs standard of care (SoC) EGFR-TKI as first-line therapy in patients (pts) with EGFR-TKI sensitising mutation (EGFRm)-positive advanced non-small cell lung cancer (NSCLC): Data from the FLAURA study. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx782] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
90
|
Ferris M, Jiang R, Ward K, Ramalingam S, Behera M, Higgins K. OA 01.06 Radiation Therapy is Associated with an Increased Incidence of Cardiac Events in Small Cell Lung Cancer Patients. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.326] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
91
|
Ohe Y, Ramalingam S, Reungwetwattana T, Chewaskulyong B, Dechaphunkul A, Lee K, Imamura F, Nogami N, Cheng Y, Cho B, Cho E, Vansteenkiste J, Voon P, Zhou C, Gray J, Hodge R, Rukazenkov Y, Soria JC. Osimertinib vs standard of care EGFR-TKI as first-line treatment in patients with EGFRm advanced NSCLC: FLAURA. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx671.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
92
|
Press R, Zhang X, Cassidy R, Ferris M, Zhong J, Steuer C, Pillai R, Owonikoko T, Ramalingam S, Patel P, Curran W, Shu H, Sica G, Higgins K. KRAS Mutant Non–small Cell Lung Cancer is Associated With Increased Risk of Salvage Whole Brain Radiation after Stereotactic Radiosurgery for Brain Metastases. Int J Radiat Oncol Biol Phys 2017. [DOI: 10.1016/j.ijrobp.2017.06.831] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
93
|
Cassidy R, Zhang X, Patel P, Shelton J, Escott C, Sica G, Rossi M, Hill C, Steuer C, Pillai R, Ramalingam S, Owonikoko T, Behera M, Force S, Fernandez F, Curran W, Higgins K. Next Generation Sequencing and Clinical Outcomes of Lung Adenocarcinomas Treated With Stereotactic Body Radiation Therapy. Int J Radiat Oncol Biol Phys 2017. [DOI: 10.1016/j.ijrobp.2017.06.588] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
94
|
Ramalingam S, Reungwetwattana T, Chewaskulyong B, Dechaphunkul A, Lee K, Imamura F, Nogami N, Ohe Y, Cheng Y, Cho B, Cho E, Vansteenkiste J, Voon P, Zhou C, Gray J, Hodge R, Rukazenkov Y, Soria JC. Osimertinib vs standard of care (SoC) EGFR-TKI as first-line therapy in patients (pts) with EGFRm advanced NSCLC: FLAURA. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx440.050] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
95
|
Abstract
Despite increasing use of bone graft in Malaysia, there was still lack of data to quantify knowledge level on bone banking among orthopaedic community who are involved in transplantation related work. Therefore, a survey on awareness in tissue banking specifically bone banking, usage and choice of bone grafts was conducted. From 80 respondents, 82.5% were aware about tissue banking however only 12.5% knew of the existence of tissue banks in Malaysia. Femoral head was the bone allograft most often used as a substitute to autograft. Only 34.8% respondents preferred irradiated bone grafts whilst 46.9% preferred nonirradiated, indicating the need to educate the importance of radiation for sterilising tissues. Exhibition was the most preferred medium for awareness programme to disseminate information about bone banking in the orthopaedic community. The professional awareness is necessary to increase the knowledge on the use of bone graft, hence to increase bone transplantation for musculoskeletal surgeries in the country.
Collapse
Affiliation(s)
- S Mohd
- Department of Orthopaedic Surgery (NOCERAL), Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
| | - N Yusof
- Department of Orthopaedic Surgery (NOCERAL), Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
| | - S Ramalingam
- Department of Orthopaedic Surgery (NOCERAL), Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
| | - W M Ng
- Department of Orthopaedic Surgery (NOCERAL), Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
| | - A Mansor
- Department of Orthopaedic Surgery (NOCERAL), Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
| |
Collapse
|
96
|
Ramanujam N, Sivaselvakumar M, Ramalingam S. Fast and parallel determination of PCB 77 and PCB 180 in plasma using ultra performance liquid chromatography with diode array detection: A pharmacokinetic study in Swiss albino mouse. Biomed Chromatogr 2017; 31. [DOI: 10.1002/bmc.4000] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2017] [Revised: 04/28/2017] [Accepted: 05/02/2017] [Indexed: 12/22/2022]
Affiliation(s)
- N. Ramanujam
- Department of Pharmacology; PSG Institute of Medical Sciences and Research; Coimbatore Tamilnadu India
| | - M. Sivaselvakumar
- Department of Molecular Medicine and Therapeutics; PSG Institute of Medical Sciences; Coimbatore Tamilnadu India
| | - S. Ramalingam
- Department of Pharmacology; PSG Institute of Medical Sciences and Research; Coimbatore Tamilnadu India
| |
Collapse
|
97
|
Cassidy R, Patel P, Zhang X, Press R, Switchenko J, Pillai R, Owonikoko T, Ramalingam S, Fernandez F, Force S, Curran W, Higgins K. Stereotactic Body Radiation Therapy for Early Stage Non–Small Cell Lung Cancer in Patients 80 Years and Older: A Multi-Center Analysis. Int J Radiat Oncol Biol Phys 2017. [DOI: 10.1016/j.ijrobp.2017.01.144] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
98
|
Paz-Ares L, Brahmer J, Hellmann M, Reck M, O'Byrne K, Borghaei H, Geese W, Lu H, Nathan F, Ramalingam S. CheckMate 227: A randomized, open-label phase 3 trial of nivolumab, nivolumab plus ipilimumab, or nivolumab plus chemotherapy versus chemotherapy in chemotherapy-naïve patients with advanced non-small cell lung cancer (NSCLC). Ann Oncol 2017. [DOI: 10.1093/annonc/mdx091.064] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
99
|
Ramalingam S, Nooh N, Al-Hezaimi K. Beta-tricalcium phosphate with adjuvant bone-marrow stem cells for bone regeneration in calvarial defects: an in vivo microcomputed tomographic and histologic experiment in rats. Int J Oral Maxillofac Surg 2017. [DOI: 10.1016/j.ijom.2017.02.722] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
100
|
Madanagopal A, Periandy S, Gayathri P, Ramalingam S, Xavier S. Molecular structure activity on pharmaceutical applications of Phenacetin using spectroscopic investigation. J Mol Struct 2017. [DOI: 10.1016/j.molstruc.2016.08.028] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|